Development of a transdermal gel for reversible male contraception.

Saved in:
Bibliographic Details
Title: Development of a transdermal gel for reversible male contraception.
Authors: Sitruk-Ware R; Center for Biomedical Research, Population Council, New York, NY, United States. Electronic address: regine@popcouncil.org., Blithe DL; Contraceptive Development Program, Division of Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States., Page ST; Department of Medicine, University of Washington, Seattle, WA, United States., Wang C; Division of Endocrinology, Department of Medicine, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, United States; Clinical and Translational Science Institute, The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, United States.
Source: Contraception [Contraception] 2025 May; Vol. 145, pp. 110830. Date of Electronic Publication: 2025 Jan 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0518 (Electronic) Linking ISSN: 00107824 NLM ISO Abbreviation: Contraception Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0518
DOI:10.1016/j.contraception.2025.110830